ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
Condition(s):Non-small Cell Lung Cancer Stage ILast Updated:October 11, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer Stage ILast Updated:October 11, 2017Unknown status
Condition(s):NSCLC Stage IVLast Updated:January 11, 2024Recruiting
Condition(s):NSCLCLast Updated:January 10, 2019Unknown status
Condition(s):NSCLCLast Updated:February 6, 2024Recruiting
Condition(s):Potentially Resectable Stage II/IIIa NSCLCLast Updated:September 26, 2019Recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:March 15, 2024Recruiting
Condition(s):Non-small Cell Lung Cancer, NSCLCLast Updated:December 7, 2022Active, not recruiting
Condition(s):NSCLCLast Updated:May 28, 2020Unknown status
Condition(s):EGFR Activating Mutation; NSCLC Stage IV; NSCLC Stage IIIB; NSCLC, RecurrentLast Updated:February 24, 2021Recruiting
Condition(s):Non-Small Cell Lung Cancer; Solid TumorLast Updated:January 31, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.